Novo CEO pressed by Senate to cut prices of obesity, diabetes prescription drugs CEO Lars Fruergaard Jørgensen explained to lawmakers the corporate would take into account new talks with insurers with regards to the list charges of Wegovy and copyright when they pledge to maintain the medicines on their formularies. https://ayahealthcareaddress08631.csublogs.com/37103071/the-basic-principles-of-healthcare-news